Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection

被引:215
作者
Sheehan, Kathleen C. F.
Lai, Koon Siew
Dunn, Gavin P.
Bruce, Allen T.
Diamond, Mark S.
Heutel, Jennifer D.
Dungo-Arthur, Corazon
Carrero, Javier A.
White, J. Michael
Hertzog, Paul J.
Schreiber, Robert D.
机构
[1] Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Monash Univ, Med Res Inst, Ctr Funct Genom & Human Dis, Melbourne, Vic 3168, Australia
关键词
D O I
10.1089/jir.2006.26.804
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herein we report the generation of mouse monoclonal antibodies (mAbs) specific for the IFNAR-1 subunit of the mouse interferon-alpha/beta (IFN-alpha/beta) receptor (MAR1 mAbs) that block type I IFN receptor signaling and biologic response induction in vitro and in vivo. These mAbs were generated from Ifnar1(-/-) mice immunized by in vivo hydrodynamic transfection with a plasmid encoding the extracellular domain (ECD) of murine IFNAR-1. All MAR1 mAbs bound native receptor expressed on cell surfaces and immunoprecipitated IFNAR-1 from solubilized cells, and two mAbs also detected IFNAR-1 by Western blot analysis. In vitro, the mAbs prevented ligand-induced intracellular signaling and induction of a variety of type I IFN-induced biologic responses but had no effect on IFN-gamma-induced responses. The most effective in vitro blocker, MAR1-5A3, also blocked type I IFN-induced antiviral, antimicrobial, and antitumor responses in vivo. We also explored whether murine IFNAR-1 surface expression required the presence of Tyk2. In contrast to Tyk2-deficient human cell lines, comparable IFNAR-1 expression was found on primary cells derived either from wild-type or Tyk2(-/-) mice. These mAbs represent much needed tools to more clearly elucidate the biochemistry, cell biology, and physiologic function of the type I IFNs and their receptor in mediating host-protective immunity and immunopathology.
引用
收藏
页码:804 / 819
页数:16
相关论文
共 65 条
[1]   T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells [J].
Afkarian, M ;
Sedy, JR ;
Yang, J ;
Jacobson, NG ;
Cereb, N ;
Yang, SY ;
Murphy, TL ;
Murphy, KM .
NATURE IMMUNOLOGY, 2002, 3 (06) :549-557
[2]   VARIOUS HUMAN INTERFERON ALPHA-SUBCLASSES CROSS-REACT WITH COMMON RECEPTORS - THEIR BINDING AFFINITIES CORRELATE WITH THEIR SPECIFIC BIOLOGICAL-ACTIVITIES [J].
AGUET, M ;
GROBKE, M ;
DREIDING, P .
VIROLOGY, 1984, 132 (01) :211-216
[3]   Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes [J].
Auerbuch, V ;
Brockstedt, DG ;
Meyer-Morse, N ;
O'Riordan, M ;
Portnoy, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :527-533
[4]   ACTIVATION OF THE PROTEIN-TYROSINE KINASE TYK2 BY INTERFERON-ALPHA/BETA [J].
BARBIERI, G ;
VELAZQUEZ, L ;
SCROBOGNA, M ;
FELLOUS, M ;
PELLEGRINI, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 223 (02) :427-435
[5]   Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA [J].
Bates, MK ;
Zhang, GF ;
Sebestyén, MG ;
Neal, ZC ;
Wolff, JA ;
Herweijer, H .
BIOTECHNIQUES, 2006, 40 (02) :199-208
[6]  
BENOIT P, 1993, J IMMUNOL, V150, P707
[7]   Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to listeria infection [J].
Carrero, JA ;
Calderon, B ;
Unanue, ER .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :535-540
[8]   EVIDENCE FOR A GAMMA-INTERFERON RECEPTOR THAT REGULATES MACROPHAGE TUMORICIDAL ACTIVITY [J].
CELADA, A ;
GRAY, PW ;
RINDERKNECHT, E ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :55-74
[9]  
CLEARY CM, 1994, J BIOL CHEM, V269, P18747
[10]   DIRECT BINDING TO AND TYROSINE PHOSPHORYLATION OF THE ALPHA-SUBUNIT OF THE TYPE-I INTERFERON RECEPTOR BY P135(TYK2) TYROSINE KINASE [J].
COLAMONICI, O ;
YAN, H ;
DOMANSKI, P ;
HANDA, R ;
SMALLEY, D ;
MULLERSMAN, J ;
WITTE, M ;
KRISHNAN, K ;
KROLEWSKI, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :8133-8142